WallStSmart

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares (XNDU)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 5507% more annual revenue ($258.90M vs $4.62M). XNDU leads profitability with a 0.0% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

XNDU

Avoid

29

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 5.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for XNDU.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

XNDU1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
163.7%10/10

Revenue surging 163.7% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

XNDU4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-126.3%2/10

ROE of -126.3% — below average capital efficiency

Free Cash FlowQuality
$-1.38M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : XNDU

The strongest argument for XNDU centers on Revenue Growth. Revenue growth of 163.7% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : XNDU

The primary concerns for XNDU are EPS Growth, Profit Margin, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

XNDU is growing revenue faster at 163.7% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 29/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Xanadu Quantum Technologies Limited is a pioneering leader in the quantum computing sector, focusing on the development and commercialization of quantum technologies for various high-impact applications. The company's innovative approach leverages superconducting qubit technology to enhance quantum computing capabilities, aimed at addressing complex computational problems across industries such as finance, pharmaceuticals, and materials science. With a strong emphasis on research and development, Xanadu is positioned to capture significant market opportunities as global demand surges for advanced computing solutions. Its Class B Subordinate Voting Shares offer investors a pathway to engage with a company poised for growth in the rapidly evolving quantum landscape.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?